We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
A guide to farming risks, potential problems with public safety and how to avoid accidents
Correct an original registration with the register office or GRO - what corrections can be made, who can apply, how long it takes
If you’re travelling abroad, it's important to take out appropriate travel insurance before you go.
The symptoms and management of yersiniosis infection (food poisoning).
How investigators and sponsors should manage clinical trials during COVID-19
Lassa virus causes Lassa fever, an acute viral haemorrhagic fever (VHF).
How to use a before-and-after study to evaluate your digital health product.
Guidance primarily aimed at local responders covering some humanitarian issues that may arise during the recovery phase of an emergency in the UK.
How to use a quasi-experimental study to evaluate your digital health product.
How to use a cost benefit analysis to evaluate your digital health product.
Examples of viral haemorrhagic fevers (VHFs) include Lassa fever, Crimean-Congo haemorrhagic fever, Marburg and Ebola virus diseases.
Covering thalidomide, lenalidomide, and pomalidomide: temporary guidance for pregnancy prevention arrangements for patients taking them during COVID-19
Find out about the symptoms of COVID-19, what to do if you or your child has them and when to get medical help.
Advice and guidance on the health needs of migrant patients for healthcare practitioners.
Guidance for industry on flexible approaches to regulation we are taking during the COVID-19 outbreak.
How to use the Non-Statutory Clearance Service offered by HMRC for all customers and their advisers.
Find out about coronavirus (COVID-19) treatments available outside of hospital, including information on free prescriptions and lateral flow tests.
How to use a crossover randomised controlled trial to evaluate your digital health product.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.